The current state of proteomics in GI oncology.
The current state of proteomics in GI oncology.
复制标题
DOI：
10.1007/s10620-008-0656-5
复制
发表时间：
2009-03
影响因子：
3.1
通讯作者：
Schade, Robert R.
中科院分区：
文献类型：
--
作者：
Lin, Ying;Dynan, William S.;Lee, Jeffrey R.;Zhu, Zhao-Hua;Schade, Robert R.
Proteomics refers to the study of the entire set of proteins in a given cell or tissue. With the extensive development of protein separation, mass spectrometry, and bioinformatics technologies, clinical proteomics has shown its potential as a powerful approach for biomarker discovery, particularly in the area of oncology. More than 130 exploratory studies have defined candidate markers in serum, gastrointestinal (GI) fluids, or cancer tissue. In this article, we introduce the commonly adopted proteomic technologies and describe results of a comprehensive review of studies that have applied these technologies to GI oncology, with a particular emphasis on developments in the last 3 years. We discuss reasons why the more than 130 studies to date have had little discernible clinical impact, and we outline steps that may allow proteomics to realize its promise for early detection of disease, monitoring of disease recurrence, and identification of targets for individualized therapy.
登录
查看更多内容
影响因子：
4.3
作者：
Engwegen, Judith Y. M. N.;Helgason, Helgi H.;Beijnen, Jos H.
通讯作者：
Beijnen, Jos H.
影响因子：
3.4
作者：
Chen, Chi-De;Wang, Chia-Siu;Lin, Kwang-Huei
通讯作者：
Lin, Kwang-Huei
影响因子：
3.4
作者：
Blanc, JF;Lalanne, C;Rosenbaum, J
通讯作者：
Rosenbaum, J
影响因子：
4.3
作者：
An, Ji-Ye;Fan, Zong-Min;Wang, Li-Dong
通讯作者：
Wang, Li-Dong
影响因子：
1.7
作者：
Chung, Jun Chul;Oh, Mi Jung;Bae, Chang Dae
通讯作者：
Bae, Chang Dae